Application 213725
- Type
- ANDA
- Sponsor
- SUN PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | EQ 40MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 62756-071 | PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Sun Pharmaceutical Industries, Inc. | ANDA | Current |
| 62756-071 | PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Sun Pharmaceutical Industries, Inc. | ANDA | Current |
| 62756-071 | PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Sun Pharmaceutical Industries, Inc. | ANDA | Current |
| 62756-071 | PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Sun Pharmaceutical Industries, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 64390 | ORIG | 2020-08-24 |